Show items per page
Elements: 10
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients Metzner, Karin J; Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; ... Günthard, Huldrych F 2014
add to browser selection
High prevalence of non-B HIV-1 subtypes in seamen and their sexual partners in Croatia Ramirez-Piedad, Martha Kathleen; Lepej, Snjezana Zidovec; Yerly Ferrillo, Sabine; Begovac, Josip 2009
add to browser selection
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir von Wyl, Viktor; Yerly Ferrillo, Sabine; Böni, Jürg; Bürgisser, Philippe; ... Günthard, Huldrych F. 2008
add to browser selection
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen Fox, Zoe; Phillips, Andrew; Cohen, Cal; Neuhaus, Jacquie; ... Lundgren, Jens 2008
add to browser selection
HIV-1 co/super-infection in intravenous drug users Yerly Ferrillo, Sabine; Jost, Stéphanie; Monnat, Martine; Telenti, Amalio; ... Perrin, Luc 2004
add to browser selection
Drug resistance mutations during structured treatment interruptions Yerly Ferrillo, Sabine; Fagard, Catherine; Gunthard, Huldrych; Hirschel, Bernard; Perrin, Luc 2003
add to browser selection
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance Yerly Ferrillo, Sabine; Vora, S.; Rizzardi, P.; Chave, J. P.; ... Perrin, Luc 2001
add to browser selection
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study Khanna, Nina; Klimkait, T.; Schiffer, V.; Irigoyen, J.; ... Battegay, M. 2000
add to browser selection
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group Joly, V.; Moroni, M.; Concia, Ercole; Lazzarin, A.; ... de Cian, W. 2000
add to browser selection
Prévalence de la transmission de virus résistant à la zidovudine en Suisse. L'étude suisse de cohorte VIH Yerly Ferrillo, Sabine; Rakik, A.; Kinloch-de-Loes, S.; Erb, P.; ... Perrin, Luc 1996